Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113K Buy
+27,400
New +$121K ﹤0.01% 1080
2025
Q2
– Sell
-66,055
Closed -$359K – 916
2025
Q1
$359K Buy
+66,055
New +$375K 0.02% 556
2024
Q2
– Sell
-24,385
Closed -$251K – 662
2024
Q1
$251K Sell
24,385
-17,742
-42% -$131K 0.02% 542
2023
Q4
$349K Buy
+42,127
New +$303K 0.03% 490

Other funds holding LFMD

Winton Group's LFMD Position: Q2 2026 in Review

Winton Group opened a new position in LifeMD (LFMD) in Q2 2026: 27,400 shares worth $113K. The stake represents ﹤0.01% of the portfolio and ranks #1080 among its holdings. This is a return to the name: Winton Group previously reported a position in LFMD as recently as Q1 2025.

Winton Group first reported a position in LFMD in Q4 2023 and has held it in 4 quarters since. The position peaked at $359K in Q1 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Winton Group held 27,400 shares of LifeMD worth $113K as of Q2 2026.
  • LifeMD was a new Winton Group position in Q2 2026.
  • LifeMD made up ﹤0.01% of Winton Group's portfolio in Q2 2026, its #1080 holding.
  • Winton Group first reported a position in LifeMD in Q4 2023 and has held it in 4 quarters since.
  • Winton Group's LifeMD position peaked at $359K in Q1 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.